A murine monoclonal antibody (928) recognizing a new epitope formed with a combination of HLA-DPA1*0201 and DPB1*0301 gene products

Human Immunology

Volumn 56, Issue 1-2, 1997, Pages 114-124

  Kishi, Hiroyuki ^a   Okumura, Akiou ^a   Tong, Jun Jie ^a   Sugiyama, Eiji ^a   Matsuno, Hiroaki ^a   Minowada, Jun ^b   Kanai, Takayuki ^c   Nishimura, Yasuharu ^c   Muraguchi, Atsushi ^a  

^a Fac Med   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; CELL SURFACE PROTEIN; EPITOPE; GENE PRODUCT; HLA DP ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 4;

ANIMAL CELL; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FETUS; FETUS LIVER; FLOW CYTOMETRY; HLA TYPING; HUMAN; HUMAN CELL; HYBRIDOMA; LYMPHOID CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, SURFACE; CELL AGGREGATION; EPITOPES; GENE EXPRESSION; GENES, MHC CLASS II; HLA-DP ANTIGENS; HUMANS; HYBRIDOMAS; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C;

EID: 0031445949     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00143-2     Document Type: Article

References (43)

1. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 16:1995;34.
2. Charron D. Molecular basis of human leukocyte antigen class II disease associations. Adv Immunol. 48:1990;107.
3. Nepom GT. Class II antigens and disease susceptibility. Annu Rev Med. 46:1995;17.
4. Ichigi Y, Naitoh K, Tokushima M, Haraoka S, Tagoh H, Kimoto M, Muraguchi A. Generation of cells with morphological and antigenic properties of microglia from cloned EBV-transformed lymphoid progenitor cells derived from human fetal liver. Cell Immunol. 149:1993;193.
5. Kasahara M, Takenouchi T, Ikeda H, Ogasawara K, Okuyama T, Ishikawa N, Wakisaka A, Kikuchi Y, Aizawa M. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies II. Distinction between HLA-Dw2 and Dw12 . Immunogenetics. 18:1984;525.
6. Hawkin S, Ishikawa N, Kasahara M, Ikeda H, Ogasawara K, Sakisaka A, Aizawa M: Two dimensional gel analyses of DR2 and MB1 molecules isolated from Dw2 and Dw12 homozygous cell lines. In Albert ED, Bauer MP, Mayer WR (eds): Histocompatibility Testing 1984. Berlin, Springer-Verlag, 1984.
7. Kasahara M, Takenouchi T, Ogasawara K, Ikeda H, Okuyama T, Ishikawa N, Moriuchi J, Wakisaka A, Kikuchi Y, Aizawa M, Kaneko T, Kashiwagi N, Nishimura Y, Sasazuki T. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. Immunogenetics. 17:1983;485.
8. Hirayama K, Nishimura Y, Tsukamoto K, Sasazuki T. Functional and molecular analysis of three distinct HLA-DR4 β-chains responsible for MLR between HLA-Dw4, Dw15 and DKT2. J Immunol. 137:1986;924.
9. Ishikawa N, Kojima H, Nakayama H, Kunikane H, Hawkin S, Fukasawa Y, Ikeda H, Ogasawara K, Kasahara M, Tajima Y, Kakuta Y, Wakisaka A, Aizawa M. Detection of a novel HLA-DQ specificity serological and immunochemical analyses by a monoclonal antibody . Immunogenetics. 26:1987;143.
10. Watson AJ, DeMars R, Trowbridge IS, Bach F. Detection of a novel human class II HLA antigen. Nature. 304:1983;358.
11. Lampson LA, Levy R. Two populations on Ia-like molecules on a human B cell line. J Immunol. 125:1980;293.
12. Okumura A, Kishi H, Tagoh H, Minowada J, Muraguchi A. Expression of 18 6/CD23 antigen on human lymphoid progenitor cell lines and phorbol 12-myristate 13-acetate (PMA)-induced microglia-shaped cells . Microbiol Immunol. 39:1995;879.
13. Kishi H, Borgulya P, Scott B, Karjalainen K, Traunecker A, Kaufman J, von Boehmer H. Surface expression of the β T cell receptor (TCR) chain in the absence of other TCR or CD3 proteins on immature T cells. EMBO J. 10:1991;93.
14. Kimura A, Sasazuki T: 11th International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991: 11th International Histocompatibility Workshop and Conference. Oxford University Press, Oxford, 1991.
15. Bodmer JG, Marsh GE, Albert ED, Bodmer WF, Dupont B, Erlich HA, Marsh B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system. Human Immunol. 41:1994;1.
16. Kappes D, Strominger JL. Human class II major histocompatibility complex genes and proteins. Ann Rev Biochem. 57:1988;991.
17. Borst J, Brouns GS, de Vries E, Verschuren MC, Mason DY, van Dongen JJ. Antigen receptors on T and B lymphocytes parallels in organization and function . Immunol Rev. 132:1993;49.
18. Viville S, Neefjes J, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D. Mice lacking the MHC class II-associated invariant chain. Cell. 72:1993;635.
19. Germain RN, Hendrix LR. MHC class II structure, occupancy and surface expression determined by postendoplasmic reticulum antigen binding. Nature. 353:1991;134.
20. Sadegh-Nasseri S, Germain RN. A role for peptide in determining MHC class II structure. Nature. 353:1991;167.
21. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature. 360:1992;474.
22. Stern LJ, Wiley DC. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell. 68:1992;465.
23. Kansas GS, Tedder TF. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and -independent adhesion in human B cell through a tyrosine kinase-dependent pathway. J Immunol. 147:1991;4094.
24. Kansas GS, Cambier JC, Tedder TF. CD4 binding to major histocompatibility complex class II antigens induces LFA-1-dependent and -independent homotypic adhesion of B lymphocytes. Eur J Immunol. 22:1992;147.
25. Mourad W, Scholl P, Diaz A, Geha R, Chatila T. Engagement of major histocompatibility complex class II molecules sustained, lymphocyte function-associated molecule 1-dependent cell adhesion. J Exp Med. 170:1990;2011.
26. Odum N, Ledbetter JA, Martin P, Geraghty D, Tsu T, Hansen JA, Gladstone P. Homotypic aggregation of human cell lines by HLA class II-, class I- and HLA-G-specific monoclonal antibodies. Eur J Immunol. 21:1991;2121.
27. Naitoh K, Ichigi Y, Miyake K, Muraguchi A, Kimoto M. Signal transmission through MHC class II molecules in a human B lymphoid progenitor cell line different signaling pathways depending on the maturational stages of B cells . Microbiol Immunol. 38:1994;967.
28. Rousset F, Malefijt RW, Slierendregt B, Aubry JP, Bonnefoy JY Defrance T, Banchereau U, de Vries JE. Regulation of Fc receptors for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL4 and IFN-γ J Immunol. 140:1988;2625.
29. Gerrard TL, Dyer DR, Mostowski HS. IL-4 and granulocyte-macrophage colony-stimulating factor selectively increase HLA-DR and HLA-DP antigens but not HLA-DQ antigens on human monocytes. J Immunol. 144:1990;4670.
30. Littman BH, Dastvan FF, Carlson PL, Sanders KM. Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (BSF-1) and IFN-γ J Immunol. 142:1989;520.
31. Becker S, Daniel EG. Antagonistic and additive effects of IL-4 and interferon-γ on human monocytes and macrophages effects on Fc receptors, HLA-D antigens, and superoxide production . Cell Immunol. 129:1990;351.
32. Trowsdale J. Genomic structure and function in the MHC. Trends Genet. 9:1993;117.
33. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:1994;215.
34. Klohe E, Fu X, Ballas M, Karr RW. HLA-DRβ chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitope. Hum Immunol. 37:1993;51.
35. Ge J, Bratlie A, Hannestad K. A human hybridoma monoclonal antibody (TrJ11) recognizing a new HLA-DR epitope shared by DR4, DR8, DR11, and DRB1*1303. Hum Immunol. 42:1995;27.
36. Kolstad A, Toubert A, Weyl D, Ge J, Hannestad K. Mapping of an epitope defined by a human hybridoma antibody (TrD3) a new HLA-B supertype associated with a subset of HLA-Bw6 . Hum Immunol. 34:1992;77.
37. Murphy DB, Lo D, Rath S, Brinster RL, Flavell RA, Slanetz A, Janeway CA Jr. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature. 338:1989;765.
38. Erlich HA, Rotter JI, Chang JD, Shaw SJ, Raffel LJ, Klitz W, Bugawan TL, Zeidler A. Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes. 45:1996;610.
39. Galeazzi M, Sebastiani GD, Passiu G, Angelini G, Delfino L, Asherson RA, Khamashta MA, Hughes GR. HLA-DP genotyping in patients with systemic lupus erythematosus correlations with autoantibody subsets . J Rheumatol. 19:1992;42.
40. Barron KS, Silverman ED, Gonzales JC, Owerbach D, Reveille JD. DNA analysis of HLA-DR, DQ, and DP alleles in children with polyarticular juvenile rheumatoid arthritis. J Rheumatol. 19:1992;1611.
41. Dekker JW, Easteal S, Jakobsen IB, Gao X, Stewart GJ, Buhler MM, Hawkins BR, Higgins DA, Yu YL, Serjeanstson SW. HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1*0602 allele. Tissue Antigens. 41:1993;31.
42. Mella JG, Roschmann E, Maier KP, Volk BA. Association of primary biliary cirrhosis with the allele of HLA-DPB1*0301 in a German population. Hepatol. 21:1995;398.
43. Oza AM, Tonks S, Lim J, Fleetwood MA, Lister TA, Bodmer JG. A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. Cancer Res. 54:1994;5101.